ID

32906

Description

Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form contains information about non-serious adverse events, occuring during the study. It should be filled in in case of drop-out due to non-serious AE.

Link

https://clinicaltrials.gov/ct2/show/NCT00241644

Keywords

  1. 11/1/18 11/1/18 -
  2. 11/17/18 11/17/18 -
  3. 11/19/18 11/19/18 - Sarah Riepenhausen
Copyright Holder

GlaxoSmithKline

Uploaded on

November 19, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644

Non-serious AE

  1. StudyEvent: ODM
    1. Non-serious AE
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject number
Description

Subject number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Non-serious Adverse Events
Description

Non-serious Adverse Events

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse event (leading to drop-outs) occurred since Visit 1 until Visit 5?
Description

if yes, please complete the following table.

Data type

boolean

Alias
UMLS CUI [1]
C1518404
Non-serious Adverse Events Leading to Drop Out
Description

Non-serious Adverse Events Leading to Drop Out

Alias
UMLS CUI-1
C1518404
Non-serious Adverse Event Number
Description

Non-serious Adverse Event Number

Data type

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
Non-serious Adverse Event Description
Description

Non-serious Adverse Event Description

Data type

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Date Non-serious Adverse Event Started
Description

Date Non-serious Adverse Event Started

Data type

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0011008
Adverse Event Started During Immediate Postvaccination Period
Description

Adverse Event Started During Immediate Postvaccination Period

Data type

boolean

Alias
UMLS CUI [1,1]
C0231291
UMLS CUI [1,2]
C1518404
Date Adverse Event Stopped
Description

Date Adverse Event Stopped

Data type

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1518404
Maximum Intensity
Description

Maximum Intensity

Data type

integer

Alias
UMLS CUI [1,1]
C1710056
UMLS CUI [1,2]
C1518404
Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship to investigational products

Data type

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0439849
Outcome
Description

Outcome

Data type

integer

Alias
UMLS CUI [1,1]
C1705586
UMLS CUI [1,2]
C1518404

Similar models

Non-serious AE

  1. StudyEvent: ODM
    1. Non-serious AE
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item Group
Non-serious Adverse Events
C1518404 (UMLS CUI-1)
Non-Serious Adverse event occurred
Item
Has any non-serious adverse event (leading to drop-outs) occurred since Visit 1 until Visit 5?
boolean
C1518404 (UMLS CUI [1])
Item Group
Non-serious Adverse Events Leading to Drop Out
C1518404 (UMLS CUI-1)
Item
Non-serious Adverse Event Number
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Code List
Non-serious Adverse Event Number
CL Item
AE1 (1)
CL Item
AE2 (2)
CL Item
AE3 (3)
CL Item
AE4 (4)
Non-serious Adverse Event Description
Item
Non-serious Adverse Event Description
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Date Non-serious Adverse Event Started
Item
Date Non-serious Adverse Event Started
date
C1518404 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Adverse Event Started During Immediate Postvaccination Period
Item
Adverse Event Started During Immediate Postvaccination Period
boolean
C0231291 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Date Adverse Event Stopped
Item
Date Adverse Event Stopped
date
C0806020 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Maximum Intensity
integer
C1710056 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
text
C1518404 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
Code List
Is there a reasonable possibility that the AE may have been caused by the investigational product?
CL Item
Yes (Y)
CL Item
No (N)
Item
Outcome
integer
C1705586 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Code List
Outcome
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae /resolved with sequelae (4)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial